2 citations
,
October 2023 in “Frontiers in Public Health” This study found that in Hidradenitis Suppurativa patients, the psychosocial subscale of Skindex-17 is most relevant for assessing quality of life across different severity levels, with irritation and pain becoming more pertinent as severity progresses.
1 citations
,
August 2025 in “Acta Dermato Venereologica” This study found that from 1990 to 2021, the global age-standardized prevalence, incidence, and years lived with disability of alopecia areata decreased, with females being more affected, and highlighted the importance of addressing psychological disorders in children with alopecia areata under age 14.
September 2025 in “International Journal of Emergency Medicine” This study reported that the increased dermatological emergency department visits during the pandemic, influenced by PPE usage and psychological stressors, highlight the need for more robust dermatology training and resources in emergency medicine to better prepare for future pandemics.
This study identified specific gut bacterial pathways that may serve as potential therapeutic targets for managing androgenetic alopecia in obese individuals.
April 2025 in “Journal of Cosmetic Dermatology” This study suggests potential causal associations between certain lipid levels, specifically HDL-C and triglycerides, and alopecia areata, highlighting the importance of lipid management as a therapeutic target.
June 2024 in “Journal of Cosmetic Dermatology” This bibliometric study found a significant increase in research publications on platelet-rich plasma for hair growth from 2006 to 2023, with a shift towards examining clinical efficacy and creating evidence-based guidelines.
4 citations
,
May 2022 in “Frontiers in Medicine” The authors concluded that trichoscopic examination can be useful for diagnosing syphilitic alopecia in patients with idiopathic alopecia, though the findings are nonspecific and further studies are needed.
2 citations
,
November 2025 in “Comprehensive Reviews in Food Science and Food Safety” This review discusses the growing role of colorimetric sensors in food safety, highlighting their potential to enhance detection accuracy and manageability, while also noting challenges such as environmental interference and the need for further industrial validation.
March 2026 in “The Aging Male” This retrospective pharmacovigilance study reviewed adverse event reports from 2004 to 2025 for drugs treating benign prostatic hyperplasia, identifying distinct safety signals for α1-blockers, 5ARIs, and PDE5I, including some potential new adverse events that require further investigation.
This study observed that mice treated with mrIL-36α showed differences in wound-induced hair neogenesis compared to those treated with PBS, indicating a potential role of mrIL-36α in hair growth after skin injury.
73 citations
,
January 2013 in “Annals of Dermatology” This study observed that patients with various types of hair loss had significantly lower serum zinc levels compared to healthy controls, suggesting zinc disturbance may play a role in the condition.
3 citations
,
January 2020 in “Annals of Dermatology” This study found that increased atypical club hair observed in microscopic hair examinations may be characteristic of telogen effluvium compared to healthy individuals and diffuse alopecia areata patients.
April 2026 in “Mendeley Data” Topical hair loss treatments have a stronger placebo effect than systemic ones.
April 2026 in “Mendeley Data” Topical treatments for hair loss have a stronger placebo effect than systemic ones.
March 2026 in “Mendeley Data” No results are reported in this dataset abstract, which details supplementary materials for a systematic review and meta-analysis on oral Janus kinase inhibitors' effectiveness and safety in children with alopecia areata, aiming to enhance transparency and interpretation of the main article's findings.
March 2026 in “Mendeley Data” In this systematic review and meta-analysis on participants aged 12 and under with alopecia areata, the authors provide supplementary tables and figures, including pooled outcomes for hair regrowth and safety of oral Janus kinase inhibitors, supporting the main findings on their effectiveness and safety.
January 2026 in “Animal Advances” In this study of four Chinese goat breeds, black goats exhibited significantly higher melanin content, while Inner Mongolian cashmere goats had longer fiber lengths. These findings highlight genetic variations in coat color and fiber length, informing future breeding programs.
June 2026 in “Health Science Reports” This study examined the genetic basis of alopecia areata by analyzing gene expression differences between patients and healthy controls, identifying critical pathways, hub genes, transcription factors, and miRNAs implicated in the disease, and suggesting potential targets for treatment.
January 2026 in “Annals of Dermatology” This study found high levels of anxiety, depression, and PTSD in dermatology patients one year after the February 6, 2023, earthquakes in Türkiye, with specific skin conditions like telogen effluvium and alopecia areata being more prevalent among those with psychological distress.
June 2026 in “Mendeley Data” This dataset provides additional exposure data and comprehensive analyses for a study on the long-term effects of particulate matter on androgenetic alopecia, but it presents no new findings.
10 citations
,
September 2020 in “Metabolites” This study found that metabolite levels in hair samples differ significantly by hair color and segment, leading to recommendations for best practices in hair metabolomic studies.
4 citations
,
May 2019 in “The World Journal of Men's Health” This study found no significant increase in depression risk associated with taking five-alpha reductase inhibitors for benign prostatic hyperplasia or alopecia, although further studies are needed to confirm these findings.
2 citations
,
May 2025 in “Frontiers in Pharmacology” In this study, analysis of FDA data revealed a substantial risk of dermatologic adverse events with aromatase inhibitors, especially anastrozole and exemestane, highlighting the importance of dermatologic monitoring during such therapies.
July 2024 in “Journal of Education For Sustainable Innovation” This study analyzed word dynamics and keyword trends in androgenetic alopecia literature over a decade using natural language processing, revealing hidden patterns and linkages that could inform future research directions and policy decisions.
November 2025 in “Free Radical Biology and Medicine” This study identified ten potential therapeutic targets and biomarkers for androgenic alopecia, with SOD1 and KL as particularly promising candidates for future therapies.
19 citations
,
January 2011 in “Annals of Dermatology” This study found that Malassezia restricta was more prevalent in patients with Malassezia folliculitis, suggesting a potential relationship between this species and the condition.
3 citations
,
April 2019 in “Clinical Therapeutics” This study identified 19 genes targeted by 29 potential drugs for topical treatment of chemotherapy-induced alopecia, suggesting avenues for drug repositioning in pharmaceutical research.
August 2026 in “Lasers in Medical Science” This review suggests that hyperspectral and terahertz imaging show promise in non-invasively assessing scalp changes associated with hair loss, but further validation is needed for clinical application.
July 2026 in “Postgraduate Medicine” Results are not reported in this response to a letter about the authors' recent meta-analysis.
December 2019 in “Journal of cosmetic dermatology” This study identified various methodological inconsistencies in systematic reviews on platelet-rich plasma therapy for pattern hair loss, suggesting a need for rigorous adherence to established guidelines.